Glioma gradea | Meningiomab | Controls | |||
---|---|---|---|---|---|
II | III | IV | |||
Sex (n) | |||||
Male | 7 | 8 | 54 | 3 | 24 |
Female | 6 | 4 | 22 | 10 | 11 |
Median age | 42 | 50 | 59 | 57 | 59 |
Range | 24–70 | 29–73 | 27–79 | 43–74 | 36–84 |
IDH status(n) | |||||
WT | 1 | 3 | 72 | NA | NA |
Mutated | 12 | 9 | 4 | NA | NA |
MGMT (n) | |||||
Non-methylated | 0 | 4 | 35 | NA | NA |
Methylated | 6 | 4 | 38 | NA | NA |
NA | 7 | 4 | 3 | NA | NA |
Steroid | no | yes | yes | yes | no |